Azitra Revenue

In the year 2024, Azitra had annual revenue of $7.50K, down -98.91%.

Revenue (ttm)

$7.50K

Revenue Growth

-98.91%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

3.16M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.50K	-678.50K	-98.91%
Dec 31, 2023	686.00K	402.00K	141.55%
Dec 31, 2022	284.00K	174.00K	158.18%
Dec 31, 2021	110.00K	-315.00K	-74.12%
Dec 31, 2020	425.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	64.24B
AbbVie	59.64B
Eli Lilly and Company	59.42B
AstraZeneca	58.13B
Novartis AG	56.37B
Novo Nordisk	49.58B

Revenue Rankings

AZTR News

2 days ago - Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American - PRNewsWire
25 days ago - Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules - PRNewsWire
5 weeks ago - Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates - PRNewsWire
6 weeks ago - Azitra, Inc. Addresses False Report Regarding Sale of Securities - PRNewsWire
2 months ago - Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris - PRNewsWire
2 months ago - Azitra Receives Notice of Non-Compliance from NYSE American - PRNewsWire
3 months ago - Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
4 months ago - Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash - PRNewsWire

More News